Answers are grounded in this paper and cite their sources.
Population aging is linked to the increase of chronic diseases and use of multiple medications. Consequently, medication non-adherence constitutes a global challenge. Therefore, we aimed to analyze the factors associated with the implementation phase of non-adherence. A multicenter cross-sectional study was conducted with older adults (age ≥ 60) in outpatient clinics of the public health system in Brazil. Medication adherence was assessed by the Measure of Adherence to Treatment (MAT), with non-adherence defined by a score below 5 points. Data were obtained through structured interviews, including the evaluation of loneliness (UCLA-BR scale) and barriers (adapted BMQ), and analyzed using multivariable logistic regression (Wald, p < 0.05). The study included 597 patients ( M age = 71.3, SD = 7.2, 56.3% female) with comorbidities (cardiovascular 84.4%, endocrinological 82.4%). Non-adherence was present in 22.4% ( n = 134) and was independently associated with recruitment site (Curitiba vs. Londrina: OR = 1.878, 95% CI [1.119, 3.153], p = 0.017), belief-related barriers ( OR = 2.259, 95% CI [1.434, 3.557], p < 0.001), and practical barriers ( OR = 2.662, 95% CI [1.361, 5.207], p = 0.004). A graded association emerged between loneliness and non-adherence: each additional point in the UCLA-BR score increased the odds of non-adherence by 3.0% ( OR = 1.030, 95% CI [1.013, 1.047], p < 0.001). The findings reveal implementation non-adherence as a sociobehavioral phenomenon. Loneliness, practical and belief barriers, and recruitment site were independently associated with higher odds of non-adherence and could be potential targets for adherence interventions in an older population.
No takes yet. Share an insight, caveat, or question.
Brazzolotto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: